1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
696E04B6EFBB6E92F00258B0800664A87
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/database-case-studies?openform
18
19openform
203.235.172.123
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25




Case Studies

Displaying 1 - 62 of 62 Total Results.

DB Image

Case Study: How Horizon Therapeutics Created an Ophthalmic Blockbuster in a Rare Disease Autoimmune Area for Thyroid Eye DiseaseDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Case Study: How Horizon Therapeutics Created an Ophthalmic Blockbuster in a Rare Dise... (ID 5760)
Companies Profiled: Amgen, Horizon Therapeutics


DB Image

Case Study: How argenx Broke Into A Captive Market To Begin Dislodging An Entrenched Market LeaderDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Case Study: How argenx Broke Into A Captive Market To Begin Dislodging An Entrenched ... (ID 5757)
Companies Profiled: argenx, Alexion Pharmaceuticals, AstraZeneca


DB Image

Skyrizi Case Study: How Compressing Cycle Time from Launch to DTC Helps Support Sales Uptake of a Rising New Blockbuster ProductDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Skyrizi Case Study: How Compressing Cycle Time from Launch to DTC Helps Support Sales... (ID 5629)
Companies Profiled: AbbVie


DB Image

Skyrizi Case Study: Developing Early Comparative Effectiveness and Outcomes Studies to Lift Launch Uptake Curve & Accelerate Planned Obsolescence of AbbVie’s Own BlockbusterDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Skyrizi Case Study: Developing Early Comparative Effectiveness and Outcomes Studies t... (ID 5625)
Companies Profiled: AbbVie


DB Image

COVID-19 Challenges for Product Launch Timelines and Activities (including launch case studies on Nexletol, Trodelvy, Vumerity, and Zeposia)Direct access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “COVID-19 Challenges for Product Launch Timelines and Activities (including case studi... (ID 5633)
Companies Profiled: AMAG Pharmaceuticals, Almirall, Alkermes, Amicus Therapeutics, more ...


DB Image

Growing Your Medical Device Business in Asia-Pacific & Latin America: Success Factors & Case Studies of Individual MarketsDirect access to this research is not included with your membership level.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from “Growing Your Medical Device Business in Asia-Pacific & Latin America: Success Factors... (ID 5504)
Companies Profiled: B.Braun, Boston Scientific, Cochlear, Fine Science Tools, more ...


DB Image

Tecfidera Case Study: Using Safety as a Springboard for Blockbuster StatusDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Tecfidera Case Study: Using Safety as a Springboard for Blockbuster Status" STUDY OVE... (ID 5360)
Companies Profiled: Biogen, Sanofi, Novartis


DB Image

Incivek Case Study: A Well Planned and Executed Launch Makes the Most of a Small Window of OpportunityDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Incivek Case Study: A Well Planned and Executed Launch Makes the Most of a Small Wind... (ID 5346)
Companies Profiled: Merck, Gilead Sciences, Vertex Pharmaceuticals


DB Image

Effexor Case Study: Using an Efficacy Message to Drive a Brand to the Top of a Crowded MarketDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Effexor Case Study: Using an Efficacy Message to Drive a Brand to the Top of a Crowde... (ID 5220)
Companies Profiled: Wyeth


DB Image

Diovan Case Study: Long-Term Brand Building in The Competitive Antihypertensive MarketDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Diovan Case Study: Long-Term Brand Building in the Competitive Antihypertensive Marke... (ID 5222)
Companies Profiled: Novartis


DB Image

Cymbalta Case Study: Using Market-Entry Delays to Develop Customer Insights that Help Grow a BlockbusterDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Cymbalta Case Study: Using Market Entry Delays to Develop Customer Insights that Help... (ID 5221)
Companies Profiled: Eli Lilly


DB Image

Onglyza Case Study: Lack of Differentiation Mutes a LaunchDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Onglyza Case Study: Lack of Differentiation Mutes a Launch" STUDY OVERVIEW Onglyza, a... (ID 5109)
Companies Profiled: Bristol-Myers Squibb, AstraZeneca


DB Image

Gardasil Case Study: Using Policy as a Springboard for Launch SuccessDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Gardasil Case Study: Using Policy as a Springboard For Launch Success" STUDY OVERVIE... (ID 5108)
Companies Profiled: Merck


DB Image

Effient Case Study: Stumbling When Taking On The Market LeaderDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Effient Case Study: Stumbling When Taking On The Market Leader" STUDY OVERVIEW The bl... (ID 5107)
Companies Profiled: Eli Lilly, Daiichi Sankyo


DB Image

Januvia Case Study: Building a Successful Launch Around KOL, Physician, Patient and Payer EducationDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Januvia Case Study: Building a Successful Launch Around KOL, Physician, Patient and P... (ID 5106)
Companies Profiled: Merck


DB Image

The Many Faces of HIV Advocacy: A Case Study of Advocacy Initiatives in the HIV/ AIDS Therapeutic AreaDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Non-members: Click here to review a complimentary excerpt from "The Many Faces of HIV Advocacy: A Case Study of Advocacy Initiatives in the HIV/ AIDS... (ID 5074)
Companies Profiled: Gilead Sciences, Abbott, Merck, GlaxoSmithKline


DB Image

Vectibix Case Study: How Amgen Collaborated with the Colon Cancer Alliance to Ensure Market EducationDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

This case study reviews how Amgen interacted with a leading patient advocacy group to support Vectibix, a colorectal cancer treatment... (ID 5067)
Companies Profiled: Amgen


DB Image

Nexavar Case Study: Using Publications and Presentations to Inform Practitioners and PatientsDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Non-members: Click here to review a complimentary excerpt from "Nexavar Case Study: Using Publications and Presentations to Inform Practitioners and ... (ID 5057)
Companies Profiled: Bayer, Onyx Pharmaceuticals


DB Image

Erbitux Case Study: Using Congresses to Educate the Oncology CommunityDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Erbitux Case Study: Using Congresses to Educate the Oncology Community" STUDY OVERVI... (ID 5060)
Companies Profiled: Bristol-Myers Squibb, Eli Lilly and Company, Merck Serono, ImClone Systems Inc.


DB Image

Avastin Case Study: Using Speaker Programs To Inform PhysiciansDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Avastin Case Study: Using Speaker Programs to Inform Physicians" STUDY OVERVIEW App... (ID 5063)
Companies Profiled: Genentech, Roche


DB Image

Onglyza Case Study: Navigating New Safety Concerns To Win Market Approval In DiabetesDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Non-members: Click here to review a complimentary excerpt from "Onglyza Case Study: Navigating New Safety Concerns to Win Market Approval in Diabetes... (ID 5068)
Companies Profiled: AstraZeneca, Bristol-Myers Squibb


DB Image

Januvia Case Study: Building A Blockbuster Product Franchise That Supports Brand LeadershipDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here to review a complimentary excerpt from "Januvia Case Study: A Blockbuster Product Franchise that Supports Brand Leadership" ... (ID 5054)
Companies Profiled: Merck


DB Image

Slentrol Case Study: Using Integrated PR Tactics to Support a Product LaunchDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Non-Members: To download a complimentary excerpt of this study, please click here... (ID 5014)
Companies Profiled: Pfizer Animal Health


DB Image

Nexium Case Study: Using PR To Reach Diverse Patient Populations and Build Bridges Between Product GenerationsDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Non-members: Click here for a complimentary excerpt of Nexium Case Study: Using PR To Reach Diverse Patient Populations and Build Bridges Between Pr... (ID 5012)
Companies Profiled: AstraZeneca


DB Image

Using Disease Management Systems to Thwart Generic Competitors: A Case StudyDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Companies seeking to develop strategies and tactics that enhance the post-patent success of products can learn from products that maintained market share in the face of generic competition... (ID 4246)
Companies Profiled: Novartis

$574.95


DB Image

Byetta Case Study: Using Medical Education as a Springboard for Product LaunchDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics, Graphics and a detailed Process Map.This document contains Metrics, Graphics and a detailed Process Map.This document contains Metrics, Graphics and a detailed Process Map.

Non-members: To download a complimentary excerpt of this study, please click here... (ID 5007)
Companies Profiled: Amylin, Eli Lilly


DB Image

Rituxan Case Study: Pre-Launch Communications to Change the Dominant Treatment ParadigmDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics and a detailed Process Map.This document contains Graphics and a detailed Process Map.

Non-members: To download a complimentary excerpt of this study, please click here STUDY OVERVIEW This case study reviews the strategy and tactics u... (ID 5006)
Companies Profiled: Genentech


DB Image

Exubera Case Study: Misjudging the MarketDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Graphics.

Non-members: To download a complimentary excerpt of this study, please click here STUDY OVERVIEW This case study reviews the failed strategy and ta... (ID 5005)
Companies Profiled: Pfizer


DB Image

Flomax Case Study:Evolving Disease State Awareness to Succeed with New Method of ActionDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics, Graphics and a detailed Process Map.This document contains Metrics, Graphics and a detailed Process Map.This document contains Metrics, Graphics and a detailed Process Map.

Non-Members: To download a complimentary excerpt of this study, please click here... (ID 5004)
Companies Profiled: Boehringer Ingelheim


DB Image

Cymbalta Case Study: Successfully Entering a Crowded Market with a New Mechanism of ActionDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and Graphics.This document contains Metrics and Graphics.

Non-members: Click here for a complimentary excerpt of Cymbalta Case Study: Successfully Entering a Crowded Market with a New Mechanism of Action... (ID 5002)
Companies Profiled: Eli Lilly and Company